Cost-effectiveness analysis of romosozumab for severe postmenopausal osteoporosis at very high risk of fracture in Mexico

• Juan Pablo Diaz Martinez ,

  Roles Conceptualization, Formal analysis, Methodology, Writing – original draft, Writing – review & editing

  * E-mail: juan.diaz.martinez@mail.utoronto.ca

  Affiliation Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Canada

  https://orcid.org/0009-0005-2836-699X

  ⨯
• Therese Aubry de Maraumont,

  Roles Conceptualization, Formal analysis, Writing – original draft, Writing – review & editing

  Affiliation Health Economics Amgen Mexico, Mexico City, Mexico

  ⨯
• Elly Natty Sánchez,

  Roles Writing – review & editing

  Affiliation Health Economics Amgen Mexico, Mexico City, Mexico

  ⨯
• Luis Miguel Camacho Cordero,

  Roles Writing – review & editing

  Affiliation Health Economics Amgen Mexico, Mexico City, Mexico

  ⨯
• Eric Yeh

  Roles Conceptualization, Formal analysis, Writing – original draft, Writing – review & editing

  Affiliation Health Economics Amgen, Thousand Oaks, CA, United States of America

  ⨯